Healthcare Triangle, Inc. (HCTI) - 10-K Summary
Business Context and Reporting Period
Company: Healthcare Triangle, Inc. (HCTI)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2024
Business Overview: HCTI is a healthcare information technology company providing cloud services, data science, and managed services to the Healthcare and Life Sciences (HCLS) industry. Key offerings include proprietary platforms (CloudEz, DataEz, Readabl.AI) and services for Electronic Health Record (EHR) implementation, interoperability, and cloud transformation.
Ownership: SecureKloud Technologies, Inc. owns approximately 45% of the company's common stock.
Key Financial Metrics
| Metric (in thousands) | 2024 | 2023 |
|---|---|---|
| Revenue | $11,696 | $33,203 |
| Cost of Revenue | $8,806 | $26,426 |
| Gross Profit | $2,890 | $6,777 |
| Net Loss | $(5,969) | $(8,686) |
| Cash and Cash Equivalents (Year End) | $20 | $1,234 |
| Operating Cash Flow | $(1,081) | $(2,151) |
| Current Ratio | 0.33 | 0.74 |
| Short-Term Borrowings | $2,650 | $3,788 |
Note: The filing text does not provide a clear value for total long-term debt as of December 31, 2024, other than noting the long-term portion of convertible notes was $0.
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased by 65% ($21.5 million) to $11.7 million. This was driven by significant drops across all segments: Software Services (-78%), Managed Services (-36%), and Platform Services (-82%).
- Customer Concentration Shift: In 2023, the top customer accounted for 52% of revenue. In 2024, the top customer accounted for 17%, and the top five customers accounted for 58% (down from 79% in 2023), indicating a diversification of the client base following the loss of a major client.
- Impairment Reversal: The company recorded a $1.71 million impairment expense in 2023 related to customer relationships. No impairment expense was recorded in 2024.
- Liquidity Deterioration: Cash and cash equivalents dropped from $1.23 million to $20,000. The current ratio fell from 0.74 to 0.33, indicating significant short-term liquidity pressure.
- Net Loss Improvement: Despite the revenue drop, the net loss narrowed from $8.7 million to $6.0 million, primarily due to the absence of the 2023 impairment charge and reduced operating expenses.
Guidance, Outlook, Risks, and Unusual Items
- Going Concern Warning: The independent auditor has issued a "Going Concern" opinion. The company has not achieved profitable operations, has negative operating cash flows, and is dependent on future equity or debt financing to continue operations. The financial statements do not include adjustments that might result from this uncertainty.
- Nasdaq Delisting Risk: On February 26, 2025, the company received a deficiency notice from Nasdaq for failing to maintain the $1.00 minimum bid price for 30 consecutive days. The company has 180 days (until August 25, 2025) to regain compliance. The Board has authorized a potential reverse stock split of up to 250:1 to address this.
- Recent Capital Raise: In a subsequent event (February 28, 2025), the company announced a private offering raising approximately $15.2 million gross proceeds ($13.68 million net) to fund working capital and acquisitions.
- Internal Control Weaknesses: Management identified a material weakness in internal controls over financial reporting due to limited resources, lack of segregation of duties, and the need for adjustments during the audit process.
- Related Party Transactions: The company relies heavily on SecureKloud (a 45% shareholder) for shared services, technical resources, and office space. In October 2024, HCTI acquired assets from SecureKloud in a common control transaction valued at $7.44 million, settled via Series B Preferred Stock.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $13.68 million net proceeds from the February 2025 offering to cover operating losses and debt obligations for the next 12 months.
- Nasdaq Compliance: Monitor the status of the reverse stock split proposal and the company's ability to meet the $1.00 minimum bid price requirement by August 2025 to avoid delisting.
- Customer Concentration: Assess the stability of the new top five customers (58% of revenue) and the risk of further concentration or churn given the previous loss of a major client.
- Debt Obligations: Review the terms of the $2.65 million in short-term borrowings and convertible notes, including maturity dates and conversion triggers, to evaluate refinancing risks.
- Internal Controls: Evaluate the company's plan to remediate the material weakness in internal controls over financial reporting.